MEDUSA PHARMACEUTICALS LTD
Company number 13261049 · Monitor this company
Executive summary
MEDUSA PHARMACEUTICALS LTD currently shows a high solvency risk due to negative net assets and a weakened liquidity position as per its latest micro-entity accounts. While compliance with filing obligations and experienced leadership are positive, the declining asset base and negative working capital warrant detailed financial and operational due diligence to evaluate the company’s viability and risk exposure before investment.
Shareholders' funds
£4,072
Balance sheet as at 2025-03-30
Overview
- Company type
- Private Limited Company
- Incorporated
- 2021-03-11
- Employees
- 2 (2025 accounts)
- Registered office
- Kingsbury House 468 Church Lane, Kingsbury, London, England, NW9 8UA
- Postcode
- NW9 8UA
- Accounts category
- Micro
Accounts
- Last made up to
- 2025-03-30
- Next due by
- 2026-12-30
- Financial year end
- 30 March
Confirmation statement
- Last statement dated
- 2026-03-10
- Next due by
- 2027-03-24
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
- 72190 Other research and experimental development on natural sciences and engineering
Officers 2 current
DR James Steven, Dr DUBOFF
Director
DR Peter John Courtenay SARKIES
Director
Competitors London
This company ranks 23 among research and experimental development on biotechnology in London.